|
HS Code |
576930 |
| Name | Bile Acid |
| Type | Biological compound |
| Chemical Formula | C24H39NO4 (for common bile acid, cholic acid) |
| Appearance | Yellowish to greenish powder or crystalline solid |
| Solubility | Soluble in water |
| Cas Number | 81-25-4 (cholic acid, primary bile acid) |
| Molecular Weight | 409.56 g/mol (cholic acid) |
| Origin | Synthesized in the liver |
| Function | Emulsification of fats and absorption of fat-soluble vitamins |
| Ph | Slightly alkaline in solution |
| Storage Conditions | Store in a cool, dry place |
| Uses | Pharmaceuticals, research, supplements |
As an accredited Bile Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The packaging for Bile Acid (25g) is a sealed, amber glass bottle with a tamper-evident cap and detailed labeling. |
| Shipping | Bile Acid is shipped in tightly sealed containers under cool, dry conditions to prevent moisture absorption and degradation. It is classified as non-hazardous, but handling with appropriate personal protective equipment is recommended. Packages are clearly labeled, and shipping complies with all applicable regulations for chemical substances to ensure safe transit. |
| Storage | Bile Acid should be stored in a tightly sealed container, away from moisture, light, and incompatible substances, preferably in a cool, dry, well-ventilated area. Room temperature (15–25°C) is usually recommended. Proper labeling and chemical safety practices should be followed. Keep away from strong oxidizing agents and acids to prevent hazardous reactions. Always consult the manufacturer’s safety data sheet (SDS) for specifics. |
Competitive Bile Acid prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to sales3@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: sales3@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
As a producer deeply rooted in fine and specialty chemicals, we’ve learned that success comes from consistency at every stage. Bile acid, one of our focus products, synthesizes years of technical refinement with a practical understanding of what downstream users look for. People in manufacturing, pharmaceuticals, nutraceuticals, and research settings ask not only for “pure” material but for predictably functional chemistry. Each batch of bile acid we ship shows that attention, with rigorous in-house testing running from raw material checks to the finished article—meeting API and food-grade specifications as required.
Our selection of bile acids covers models such as cholic acid and deoxycholic acid, both as individual isolates and in tailored blends. Each kind serves different biochemical pathways. The production steps amount to more than a technical translation of research literature: from initial extraction to fractional crystallization and multiple re-purifications, every single stage stacks up to control both purity and consistency. Inputs—whether sourced from animal origin, plant-based alternatives, or via synthetic routes—get standardized using analytical benchmarks that include HPLC, GC-MS, IR, and precise microbial testing. A batch passes to packaging only after matching those designated benchmarks, with COA and technical guidance available for each lot leaving our facilities.
Specifications in bile acid supply aren’t just about achieving a certain percentage purity. They involve controlling for micro-contaminants: sodium, potassium, moisture, and trace solvent residues, all of which could impact biological studies or formulation robustness. For example, the deoxycholic acid we manufacture regularly meets 99%+ purity by HPLC, as measured in-house with a validated method. Users focused on clinical or diagnostic work often ask about other parameters, such as endotoxin content or BSE/TSE status, so we audit our supply chain for origin and compliance.
Bile acids touch a wide swath of industries. In pharmaceutical R&D, they support studies of lipid digestion, absorption mechanisms, and drug metabolism. Finished formulations—especially those looking to boost bioavailability for lipophilic drugs—directly use our cholic acid in both pilot- and production-scale runs. Nutraceuticals tend to pull on blends or isolates, either for direct tablet/capsule inclusion or as key intermediates in conjugate production. Biological research sometimes requires specific isotopic labeling, so we also craft custom variants for tracer studies and analytical standards work.
In the biochemical arena, bile acids operate as detergents or solubilizers. Labs request fine control over salt form, pH, and batch homogeneity. A pharma customer we supply prefers sodium cholate for improved dissolution behavior under intestinal simulation—demonstrating how changing just the cation can steer performance, not just the molecular backbone.
Manufacturing isn’t one-size-fits-all. We’ve trialed everything from older, solvent-heavy protocols to newer, greener processes that reduce both waste and risk of unwanted byproducts. Years back, the fractionation step yielded product with inconsistent hydration states, affecting yield and downstream crystallization. We modified the sequence, switching to semi-batch reactors and tightening temperature controls, and have since noted repeatable crystal morphology. Trace water molecules trapped in the matrix can ruin batch reproducibility; even a difference of 0.3% can change dissolution rates. We keep those values inside narrow limits, not just for regulatory comfort, but to eliminate formulation headaches for our customers.
Enzyme-catalyzed steps sometimes present hang-ups due to variance in bio-source. In direct synthesis from sterols, absence of batch-to-batch consistency becomes visible at the tank scale, showing up in melting point deviations or off-spec color. We’ve learned that standardizing not only inputs, but also operator handling instructions, limits that wobble. Audits of finished product involve multi-point random sampling—there’s no point in chasing paperwork perfection without physical spot-checking, particularly in lots destined for regulated human health uses.
Market sources range from basic “commodity” grades—often mixtures with broader impurity profiles—to research-purity isolates. Certain traders offer generic bile acid mixtures that may contain up to five primary bile acids and a slew of minor analogues. We choose to specialize, providing customers either the isolated molecule or, if blends are preferred, mixtures with documented composition and individual batch traceability. Side-by-side trials show how minor ‘unknowns’ can throw off results in sensitive enzyme inhibition assays; we stake our reputation on listing components down to the minor percentages whenever possible.
Just last year, a customer in the analytical chemistry sector brought in several market samples for parallel testing. The “high purity” offering from a generic distributor showed a cholic acid content well below its label claim, with interfering peaks in the HPLC chromatogram. Our product, pulled straight from a manufacturing lot, demonstrated a clean single peak—traceable back three steps in the batch record. Fewer unknowns mean more reliable results on the bench, a pattern that repeats itself at nearly every scale of production.
Pharma groups working on novel oral therapeutics tend to push us for endotoxin control, even when the intended use isn’t ultimately injectable. Some bile acid salts attract strict specifications around dissolution profile, because one customer’s application puts them in dissolution test media for stability trials. Research labs come at it differently, demanding small lots with absolute structure confirmation via NMR and even isotopic fingerprints. In nutritional supplement runs, bulk lots sometimes pass through our quality control interface for a second filter stage, to meet evolving consumer-facing purity standards.
Industry makes demands as it reacts to both regulatory pressure and market innovation. Some applications pivot on making APIs more available through bile acid-based carriers, so we maintain a flexible production line that allows us to shift between a kilogram and multi-ton scale in a matter of days. Our documentation shows the chemical details that matter—full chromatograms, details on residual solvents, particle size data for certain solid forms. These reflect not just regulatory compliance but the working knowledge of end-users who can’t afford surprises downstream.
Those accustomed to handling pure bile acid appreciate that the powder can be both hygroscopic and sensitive. Our operators work in climate-controlled rooms, using steel bins and anti-static protocols to limit static charge pickup. Hard clumping from premature hydration costs time and disrupts automated dosing equipment in customer plants. We pivoted toward double-lining packages some years ago. Drum liners and tamper-proof seals keep the material safe as it travels, not just for regulatory checkboxes but to save rework further down the supply chain. These interventions came about through real-world troubleshooting, not boardroom edicts.
For customers running round-the-clock facilities, we’ve learned prompt communication on residual shelf-life, re-test intervals, and shipment temperature requirements minimizes expensive last-minute substitutions. Documentation includes a timeline for best-use and storage, along with tailored support if a customer encounters caking or flowability issues. Logistics shouldn’t outstrip the product’s natural lifetime—a detail we respect by controlling conditions both in-house and in-transit.
Chemical manufacturers face scrutiny over both source and downstream fate of specialty chemicals. For bile acids, we scrutinized our origin pipeline. Early partnerships leaned heavily on animal byproduct supply, which, while traditional, may bring sourcing and traceability headaches. Switching some production volume to plant-source sterols, then going through multi-step stereo-specific synthesis, allowed us to shrink the animal-derived fraction each year—without compromising product identity or customer confidence.
Waste minimization matters on two fronts: solvent recovery (now routinely above 80% on our lines) and eliminating untreated effluent. We install closed-system reactors and batch isolation units to keep air and liquid emissions at or below local maximums. Several customers ask for Life Cycle Assessment (LCA) reports on their purchased lots, tracking total carbon and water footprints. Even if not always mandatory, keeping those metrics documented helps us refine future investments.
Though the chemistry underlying bile acid production is mature, customer needs never stop shifting. We keep R&D spends focused on two paths: upscaling green synthesis routes and tuning molecular form factors. Some customers in the biotechnology field request bile acids not just for solubilization, but as tools for membrane trafficking studies, with custom labeling and activity verification. Large-scale nutraceutical blenders want lower-dust, free-flowing forms to fit with newer continuous manufacturing lines. Feedback led us to trial granulated and micronized bile acid formats, running comparative dissolution and stability tests before wide release.
We also keep an eye on evolving pharmacopoeial standards. USP and EP monographs shift incrementally, so we have learned to build flexibility into protocols and keep an open line of dialogue with regulatory specialists. If guidance changes on heavy metals, microbial counts, or trace animal antigens, we engage fast, updating our document set and retraining operators in real time.
Being a manufacturer, not just a supplier, puts us in close contact with users—be they process chemists, regulatory affairs staff, or bench researchers. Each technical inquiry signals an opportunity to fine-tune production, documentation, or delivery. If a process scientist calls about an unexpected spot in an analytical scan, we’re able to walk the batch chain and interpret the chromatograms with them, often identifying source changes or timeline quirks that reveal the cause. That’s the value added by years of operator continuity and technical know-how.
Transparency works both ways. The more our customers bring us into their process, the better we can anticipate problems and head off mishaps before they scale. A nutraceutical partner needed allergen-free certification at short notice; we managed cross-contact audits, put in added cleaning cycles, and issued new certificates—all without holding up their downstream schedule. These adjustments aren’t possible without direct manufacturing control and a feedback-friendly culture inside our production floor.
From the outside, bile acid can seem just like another white powder, a line item on a purchase form. For us, it’s a product that has moved through worker hands, technical minds, and careful equipment—bearing the trace of every operator’s experience. The labor behind each drum links directly to the people and processes on the receiving end. Years of working with end-users showed us how small tweaks—a tighter moisture spec, a more robust packaging choice, a more detailed certificate—help make the difference between a run that’s smooth and one that hits a snag.
For those in pharmaceuticals, advanced materials, molecular biology, or analytical science, using well-made bile acid isn’t about adding a filler to a mix. It’s about receiving a consistently reliable chemical, knowing its story from the earliest raw input to the final packaged lot. Our role involves not just making but also listening, refining, and standing behind every shipment. We never remove the human factor. Our teams know the inside of our reactors and the quirks of every downstream application. Building that trust is as much a product as the bile acid itself.